- Home
- OMI vs QURE Comparison
OMI vs QURE Comparison
Compare OMI & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMI
- QURE
- Stock Information
- Founded
- OMI 1882
- QURE 1998
- Country
- OMI United States
- QURE Netherlands
- Employees
- OMI N/A
- QURE N/A
- Industry
- OMI Medical Specialities
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- OMI Health Care
- QURE Health Care
- Exchange
- OMI Nasdaq
- QURE Nasdaq
- Market Cap
- OMI 1.0B
- QURE 711.1M
- IPO Year
- OMI N/A
- QURE 2007
- Fundamental
- Price
- OMI $9.52
- QURE $13.39
- Analyst Decision
- OMI Hold
- QURE Buy
- Analyst Count
- OMI 7
- QURE 9
- Target Price
- OMI $16.07
- QURE $38.25
- AVG Volume (30 Days)
- OMI 2.6M
- QURE 895.1K
- Earning Date
- OMI 05-02-2025
- QURE 05-06-2025
- Dividend Yield
- OMI N/A
- QURE N/A
- EPS Growth
- OMI N/A
- QURE N/A
- EPS
- OMI N/A
- QURE N/A
- Revenue
- OMI $10,700,883,000.00
- QURE $27,119,000.00
- Revenue This Year
- OMI $3.58
- QURE $33.81
- Revenue Next Year
- OMI $2.57
- QURE $247.07
- P/E Ratio
- OMI N/A
- QURE N/A
- Revenue Growth
- OMI 3.55
- QURE 71.17
- 52 Week Low
- OMI $6.07
- QURE $3.73
- 52 Week High
- OMI $28.35
- QURE $19.18
- Technical
- Relative Strength Index (RSI)
- OMI 51.27
- QURE 50.07
- Support Level
- OMI $9.50
- QURE $11.45
- Resistance Level
- OMI $10.43
- QURE $12.77
- Average True Range (ATR)
- OMI 0.67
- QURE 1.17
- MACD
- OMI 0.47
- QURE 0.14
- Stochastic Oscillator
- OMI 79.59
- QURE 86.18
About OMI Owens & Minor Inc.
Owens & Minor Inc distributes consumable medical supplies to a variety of providers. The business is under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment manufactures and sources medical surgical products through its production and kitting operations and provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies. Majority of the revenue is generated from Products & Healthcare Services segment.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.